Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis

BACKGROUND: Nintedanib slows disease progression in patients with Idiopathic Pulmonary Fibrosis (IPF) by reducing decline in Forced Vital Capacity (FVC). The effects of nintedanib on abnormalities on high-resolution computed tomography scans have not been previously studied. OBJECTIVE: We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Lancaster, Lisa, Goldin, Jonathan, Trampisch, Matthias, Kim, Grace Hyun, Ilowite, Jonathan, Homik, Lawrence, Hotchkin, David L., Kaye, Mitchell, Ryerson, Christopher J., Mogulkoc, Nesrin, Conoscenti, Craig S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539538/
https://www.ncbi.nlm.nih.gov/pubmed/33088361
http://dx.doi.org/10.2174/1874306402014010022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539538/
https://www.ncbi.nlm.nih.gov/pubmed/33088361
http://dx.doi.org/10.2174/1874306402014010022

Ejemplares similares